1. Kim BN. Oral agents for the treatment of orthopedic infections caused by methicillin-resistant staphylococci. Infect Chemother. 2011. 43:322–338.
Article
2. Widmer AF. New developments in diagnosis and treatment of infection in orthopedic implants. Clin Infect Dis. 2001. 33:Suppl 2. S94–S106.
Article
3. Perlroth J, Kuo M, Tan J, Bayer AS, Miller LG. Adjunctive use of rifampin for the treatment of
staphylococcus aureus infections: a systematic review of the literature. Arch Intern Med. 2008. 168:805–819.
Article
4. Turnidge J, Grayson ML. Optimum treatment of staphylococcal infections. Drugs. 1993. 45:353–366.
Article
5. Karamanis EM, Matthaiou DK, Moraitis LI, Falagas ME. Fluoroquinolones versus beta-lactam based regimens for the treatment of osteomyelitis: a meta-analysis of randomized controlled trials. Spine. 2008. 33:E297–E304.
6. Adra M, Lawrence KR. Trimethoprim/sulfamethoxazole for treatment of severe
staphylococcus aureus infections. Ann Pharmacother. 2004. 38:338–341.
Article